Advertisement
Screener

PROTHENA CORPORATION PUBLIC LIMITED COMPANY (PRTA) Material Contracts, 2016

PROTHENA CORPORATION PUBLIC LIMITED COMPANY Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2016-11-28: Form 8-K; Exhibit 10.1; Description Retirement Transition Letter Agreement dated November 21, 2016..
  • 2016-11-04: Form 8-K/A; Exhibit 10.1; Description EXHIBIT 10.1 EMPLOYMENT AGREEMENT DATED NOVEMBER 2, 2016 - GENE G. KINNEY.
  • 2016-05-25: Form 8-K; Exhibit 10.1; Description EXHIBIT 10.1 AMENDED AND RESTATED 2016 LTIP.
  • 2016-05-04: Form 10-Q; Exhibit 10.2.A; Description Sublease, dated as of March 22, 2016, by and between Prothena Biosciences Inc and Amgen Inc..
FiledFormExhibitDescription
2016-11-288-K10.1Retirement Transition Letter Agreement dated November 21, 2016.
2016-11-048-K/A10.1EXHIBIT 10.1 EMPLOYMENT AGREEMENT DATED NOVEMBER 2, 2016 - GENE G. KINNEY
2016-05-258-K10.1EXHIBIT 10.1 AMENDED AND RESTATED 2016 LTIP
2016-05-0410-Q10.2.ASublease, dated as of March 22, 2016, by and between Prothena Biosciences Inc and Amgen Inc.
2016-05-0410-Q10.2.BConsent to Sublease Agreement, dated as of March 28, 2016, by and among Prothena Biosciences Inc, Amgen Inc. and HCP BTC, LLC
2016-05-0410-Q10.1Offer letter, dated January 20, 2016, by and between Prothena Biosciences Inc and David McNinch

Similar stocks

Stock NameCountryMarket CapPE Ratio
DiaMedica Therapeutics Inc. (DMAC)United States$0.423B-10.11
CYPHERPUNK TECHNOLOGIES INC. (CYPH)United States$0.438B-75.63
Atea Pharmaceuticals, Inc. (AVIR)United States$0.414B-2.26
ARS Pharmaceuticals, Inc. (SPRY)United States$0.414B-3.70
Quoin Pharmaceuticals Ltd. (QNRX)$0.443B-17.85
RELMADA THERAPEUTICS, INC. (RLMD)United States$0.406B-11.92
Opus Genetics, Inc. (IRD)United States$0.406B-3.16
Arcturus Therapeutics Holdings Inc. (ARCT)$0.402B-2.05
GALECTIN THERAPEUTICS INC (GALT)United States$0.399B-11.06
MapLight Therapeutics, Inc. (MPLT)United States$0.459B-7.10